Skip to content
Search AI Powered

Latest Stories

Veterans Denied: Government's Indifference to Cannabis and Psychedelics Continues to Hinder Healing

Republicans Strike Down All Marijuana And Psychedelics Amendments From NDAA

Government's Indifference to Cannabis and Psychedelics Continues to Hinder Healing
Government's Indifference to Cannabis and Psychedelics Continues to Hinder Healing

As the National Defense Authorization Act (NDAA) takes center stage in shaping the future of the United States Department of Defense, Congress missed a crucial opportunity to prioritize the well-being of our nation's veterans. 

Amendments that would have expanded access to cannabis and psychedelics for medical purposes were recently rejected in a Rules Committee vote, leaving veterans stranded in their ongoing battle against post-traumatic stress disorder (PTSD) and other ailments.


One such amendment, sponsored by Rep. Dan Crenshaw, sought to create a DOD grant program funding research on the therapeutic benefits of psilocybin and MDMA for treating PTSD and traumatic brain injury (TBI). 

Surprisingly, this proposal garnered support from both Democrats and Republicans, only to be dismissed due to stricter oversight requirements. The decision highlights the government's enduring failure to recognize the urgent need for innovative solutions in veterans' healthcare.

Additionally, a cannabis-related amendment, put forth by House Veterans Affairs Chair Mark Takano, proposed establishing a medical cannabis pilot program for veterans in the VA health care system. This initiative aimed to grant access to medical cannabis for veterans diagnosed with PTSD, depression, or anxiety. 

Nevertheless, it was also blocked from inclusion in the NDAA, denying veterans a potentially safer and more effective alternative to traditional treatments.

These decisions are a blow to the countless veterans who have found relief and improved quality of life through the use of cannabis and psychedelics. Multiple studies, including a recent survey of over 500 military veterans, demonstrate that medicinal cannabis can lead to a greater quality of life and a reduced reliance on prescription and over-the-counter medications. It is disheartening to see the government overlook such compelling evidence in favor of over-politicized and antiquated stances on cannabis and psychedelics.

The consequences of these omissions are far-reaching. Veterans are left to grapple with debilitating conditions, struggling to access effective treatment options. For those who have exhausted traditional remedies, cannabis and psychedelics offer new hope, paving the way for innovative approaches in managing mental health issues.

Moreover, veterans are being denied access to potential breakthroughs in mental health treatments. Rep. Ken Buck's proposal, which recommended recognizing MDMA as a viable treatment for PTSD, aimed to push the Department of Veterans Affairs (VA) to develop a plan for its approval. This decision represents a missed opportunity to explore promising avenues of healing for our brave servicemen and women.

Congress must acknowledge the growing support for marijuana reform and the positive impact it has on veterans. Medicinal cannabis can serve as a crucial harm-reduction tool, reducing the need for numerous pharmaceutical medications and other substances that often come with dangerous side effects. Veterans deserve access to alternative treatments that have shown real promise in alleviating their suffering.

It is long-past time for the government to prioritize the well-being of our veterans over outdated misconceptions about cannabis and psychedelics. By supporting these and similar amendments, Congress can take a significant step towards honoring the service and sacrifice of our veterans. Failure to do so will perpetuate the government's neglect of the very heroes it should be standing beside. 

As the debates on marijuana reform and psychedelics continue, we implore Congress to seize the opportunity to enact meaningful change for veterans. Let us not overlook the overwhelmingly positive results veterans have experienced firsthand with both cannabis and psychedelics. By including these amendments in the NDAA, our government can finally demonstrate its unwavering commitment to those who have risked their lives to protect our nation's freedom. 

Additional information on Marijuana and Veterans is available from the NORML Fact Sheet, Marijuana and Veterans Issues.’

More For You

Union Square Travel Agency: A Cannabis Store (USQTA)
Union Square Travel Agency: A Cannabis Store (USQTA)
Will Ellis

Union Square Travel Agency: Where Wanderlust Meets the Enchantment of Cannabis

Come fly with me, let's fly, let's fly away
If you can use some exotic weed
There's a new dispensary on Broadway
Come on, fly with me, we'll float down in the blue…

Frank Sinatra

Union Square Travel Agency: A Cannabis Store (USQTA) is poised to revolutionize the cannabis dispensary experience in New York City with its expansion to a new 2800-square-foot permanent space located at 835 Broadway at 13th St., one block south of Union Square. 

Keep ReadingShow less
Socrates contemplates the Greek government's confusion over medical cannabis.
Socrates contemplates the Greek government's confusion over medical cannabis.

Medical Cannabis in Greece? The Greek Government Has No Idea What It’s Doing

The Greek government has finally given the approval for THC-rich medical cannabis cultivation and sale.

The Minister of Development Adonis Georgiadis, who is apparently now spearheading cannabis reform in the country, even issued a “mea culpa,” admitting that he and his colleagues had been wrong about cannabis in the past.

Keep ReadingShow less
What's Going on With New York's Legal Cannabis Rollout
What's Going on With New York's Legal Cannabis Rollout

What’s Going on with New York’s Legal Cannabis Roll Out? 

The New York cannabis industry is facing a complex and challenging landscape as it transitions from a medical marijuana program to a fully legal recreational market. Despite the recent legalization of adult-use cannabis in the state, there are still many issues to be addressed, including regulatory compliance, licensing, distribution, capital and equity concerns, and of course, litigation.

Recently, several lawsuits have been filed against the New York State Cannabis Control Board (CCB) and the Office of Cannabis Management (OCM), which are the agencies responsible for overseeing the state's cannabis industry.

Keep ReadingShow less
NY's Cannabis Industry Gets Some Tax Relief Thanks to Gov. Hochul
NY's Cannabis Industry Gets Some Tax Relief Thanks to Gov. Hochul

A New Dawn for NYC Cannabis Businesses As Gov. Hochul Provides Tax Relief

New York’s governor, Kathy Hochul, has recently signed groundbreaking legislation providing much-needed tax relief to New York City marijuana businesses, a significant move in a landscape where federal deductions under Internal Revenue Service (IRS) code 280E are currently off-limits. This decisive action comes after a five-month wait following the Senate and Assembly’s approval of the proposal, underscoring the state’s commitment to supporting the burgeoning cannabis industry, according to Marijuana Moment.

The legislation represents a pivotal step in addressing the unique tax challenges faced by cannabis businesses. Historically, these entities have been hamstrung by federal policies that severely limit their ability to make standard business deductions. The new law seeks to bridge this gap at the city level, following a similar state-level initiative included in last year's separate budget bill. However, New York City’s distinct tax laws remained unaffected by the earlier state-level change, necessitating this targeted intervention.

Keep ReadingShow less
On The Revel's Buyers Club Electrifies New York's Cannabis Industry - The Bluntness
On The Revel's Buyers Club Electrifies New York's Cannabis Industry - The Bluntness

Revelry Buyers' Club Electrifies New York's Cannabis Industry

The iconic Basilica Hudson was buzzing with energy and excitement on Thursday as hundreds, (maybe even thousands?) of cannabis industry leaders, retailers, growers, producers, and top brands from across the state converged for the third annual Revelry Buyers' Club. The exclusive Buyers Club, organized by On The Revel, has become a centerpiece event for New York's rapidly expanding legal cannabis market.

For all of New York's trials and tribulations in its legalization journey, an atmosphere of conviviality and entrepreneurial spirit filled the air as attendees connected over the latest products, forged new partnerships, and shared insights about the industry's challenges, opportunities and evolution. The diversity and dynamism of the crowd reflected the vibrant spectrum of New York's cannabis community itself.

Keep ReadingShow less